Clinical Trials

96 enrolled

GastrointestinalThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05259319 2023-10-17

IMMUNOs-SBRT

GenitourinaryHead & NeckThoracic

92 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT05347628 2023-08-21

Assessing the Safety and Efficacy of PLB1004 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

91 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05739006 2023-08-02

Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies

131 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05965102 2023-07-28

Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer

31 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05798533 2023-07-10

Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)

6 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT04763083 2023-07-07

First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

DermatologicLymphoidOther hematologic neoplasmThoracic

90 enrolled

Carcinoma, Non-Small-Cell Lung, Lymphoma, Follicular, Melanoma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05780307 2023-06-07

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

BreastGastrointestinalThoracic

48 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT03217669 2023-05-03

Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy

15 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05798546 2023-04-04

Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

21 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05555212 2023-03-28

To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation

72 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05430386 2023-02-14

Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC

174 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03634982 2022-09-01

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

133 enrolled

Urinary Bladder Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Noonan Syndrome, Ovarian Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Skin Neoplasms, Thoracic Neoplasms, Uterine Neoplasms, Neoplasms, Squamous Cell

NCT05369312 2022-06-21

Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients

230 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT04052412 2022-05-13

Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer

2 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02637531 2022-04-04

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

BreastDermatologicEndocrineOther solid neoplasmThoracic

219 enrolled

Carcinoma, Non-Small-Cell Lung, Melanoma, Mesothelioma, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT05223595 2022-02-04

A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02929290 2021-09-13

Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05008861 2021-08-17

Gut Microbiota Reconstruction for NSCLC Immunotherapy

Carcinoma, Non-Small-Cell Lung

NCT02824965 2021-07-07

Pembrolizumab + CVA21 in Advanced NSCLC

11 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04942301 2021-06-30

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

24 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01711697 2021-06-23

An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

16 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03852823 2021-04-30

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours

GynecologicLymphoidOther solid neoplasmThoracic

192 enrolled

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lymphoma

NCT04142931 2021-03-24

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT03976856 2021-03-03

Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04448379 2020-12-28

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

48 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04667975 2020-12-16

CKD-702

74 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04487093 2020-07-27

Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT03987867 2020-07-07

Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

NCT04193098 2020-07-07

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

10 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04397926 2020-06-11

Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04153799 2020-05-12

Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer

11 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04175158 2019-11-22

Clinical Trial in Chinese Healthy Volunteers of GB222

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03910127 2019-10-30

Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03396497 2019-09-25

Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer

17 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04059874 2019-08-16

Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate

Carcinoma, Non-Small-Cell Lung

NCT03603262 2019-01-28

Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC

85 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02956551 2018-05-31

SKLB1608

Carcinoma, Non-Small-Cell Lung

NCT03527251 2018-05-30

SEQUENCE

10 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03076372 2018-02-27

A Study Evaluating MM-310 in Patients With Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

34 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03198923 2017-09-25

Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT03282435 2017-09-14

Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody

Carcinoma, Non-Small-Cell Lung

NCT02695550 2017-03-09

Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03057340 2017-02-20

The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells

Carcinoma, Non-Small-Cell Lung, Sialorrhea

NCT03050411 2017-02-10

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer